Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. May 15, 2024; 16(5): 1796-1807
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1796
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1796
Factors | M + H group (n = 66) | L group (n = 38) | P value |
Age (yr) | 0.703 | ||
≥ 60 | 39 | 21 | |
< 60 | 27 | 17 | |
Sex | 0.855 | ||
Male | 37 | 22 | |
Female | 29 | 16 | |
BMI (kg/m2) | 0.572 | ||
≥ 25 | 19 | 9 | |
< 25 | 47 | 29 | |
Tumor site | 1.069 | ||
Upper | 23 | 12 | |
Middle | 20 | 9 | |
Lower | 23 | 17 | |
Tumor type | 0.797 | ||
Protruded | 10 | 5 | |
Ulcerative | 47 | 26 | |
Infiltrating | 9 | 7 | |
T staging | 0.786 | ||
T1-T2 | 40 | 22 | |
T3-T4 | 26 | 16 |
- Citation: Mu RQ, Lv JW, Ma CY, Ma XH, Xing D, Ma HS. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging parameters and serum tumor markers in rectal carcinoma prognosis. World J Gastrointest Oncol 2024; 16(5): 1796-1807
- URL: https://www.wjgnet.com/1948-5204/full/v16/i5/1796.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i5.1796